MARKET

ATAI

ATAI

Atai Life Sciences B.V.
NASDAQ
2.720
+0.100
+3.82%
After Hours: 2.710 -0.01 -0.37% 17:34 07/14 EDT
OPEN
2.690
PREV CLOSE
2.620
HIGH
2.750
LOW
2.610
VOLUME
2.92M
TURNOVER
--
52 WEEK HIGH
2.985
52 WEEK LOW
1.030
MARKET CAP
577.03M
P/E (TTM)
-2.9798
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ATAI last week (0707-0711)?
Weekly Report · 10h ago
Weekly Report: what happened at ATAI last week (0630-0704)?
Weekly Report · 07/07 11:50
The MAHA Movement Loves Psychedelics. Should Wall Street? -- Heard on the Street
The Wall Street Journal · 07/06 09:30
ATAI Life Sciences: Promising Phase 2b Results and Strong Financial Position Boost Price Target
TipRanks · 07/04 11:35
Psychedelic: atai Life Sciences, Beckley Psytech report BPL-003 study results
TipRanks · 07/03 14:30
Aegis Capital Remains a Buy on ATAI Life Sciences (ATAI)
TipRanks · 07/02 19:37
Atai: Critical Study Win Sets Up Double Approval Shot For Psychedelics In TRD
Seeking Alpha · 07/02 18:29
ATAI Life Sciences Price Target Raised to $12.00/Share From $11.00 by Canaccord Genuity
Dow Jones · 07/02 15:35
More
About ATAI
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company. The Company focused on developing treatments for mental health disorders. The Company's pipeline includes psychedelic and non-psychedelic compounds targeting depression, anxiety, and other unmet needs in psychiatry.

Webull offers ATAI Life Sciences NV stock information, including NASDAQ: ATAI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ATAI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ATAI stock methods without spending real money on the virtual paper trading platform.